Navigation Links
Capillary Action Absorbant Pads; 50 pcs (SIGNET) from Covance Research Products, Inc

ProductsCapillary Action Absorbant Pads; 50 pcs (SIGNET) from Covance Research Products, Inc
Company Covance Research Products, Inc
Item Capillary Action Absorbant Pads; 50 pcs (SIGNET)
Price $208.00
Description Signet offers the most comprehensive, cost-effective solution to your TechMate Detection requirements. We have incorporated unprecedented quality into both our products and service capabilities. This includes proven detection chemistries and antibodies that have been optimized to the TechMate protocol. It also includes our competitively priced accessories that can be purchased individually as well as in volumes customized to your setting.
Info Covance Research Products, IncCovance Research Products, Inc
P.O. Box 7200
Denver, Pennsylvania 17517

Customer Service:
800-345-4114 (Toll Free)
717-336-4921

Fax Number:
717-336-5344

Web Site: http://www.crpinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. 10X Capillary Electrophoresis Running Buffer from Sigma-Aldrich
2. Paragon CZE 2000 Capillary Electrophoresis System from Beckman Coulter
3. Capillary Electrophoresis System from Agilent Technologies
4. Capillary Action Water Wash, 1L (SIGNET) from Covance Research Products, Inc
5. Capillary Action Trays (SIGNET) from Covance Research Products, Inc
6. FAST RED Chromogen System (SIGNET) from Covance Research Products, Inc
7. NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
8. NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
9. beta-Amyloid 1-40 ELISA Kit (SIGNET) from Covance Research Products, Inc
10. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 50 Test, Murine, AEC Detection Kit (SIGNET) from Covance Research Products, Inc
11. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 50 Test, Multi-Species, AEC Detection Kit (SIGNET) from Covance Research Products, Inc
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
... A study published in this week,s online issue of ... sensitive method for detecting methylation-associated cancers. ... of methyl groups has been established as a common ... levels of DNA methylation, which effectively disrupt the genes ...
... research shows that air pollution in eastern China has reduced ... and decreased by 23 percent the number of days of ... results suggest that bad air quality might be affecting the ... health and environmental problems. The study links for the ...
... Dresden research team used laser tweezers to measure the ... track. The team found that also within our ... are restrained in its operationusually by far not as ... experimental measurements of protein friction could help researchers to ...
Cached Biology News:Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 2Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 3The sky is not falling: Pollution in eastern China cuts light, useful rainfall 2The sky is not falling: Pollution in eastern China cuts light, useful rainfall 3The sky is not falling: Pollution in eastern China cuts light, useful rainfall 4Bionanomachines -- proteins as resistance fighters 2
(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...
(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3